Cargando…
Decreased clot burden is associated with factor XIII Val34Leu polymorphism and better functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis
BACKGROUND: Intravenous thrombolysis using recombinant tissue plasminogen activator remains the mainstay treatment of acute ischemic stroke (AIS), although endovascular treatment is becoming standard of care in case of large vessel occlusions (LVO). To quantify the thrombus burden in LVO, a semiquan...
Autores principales: | Szegedi, István, Orbán-Kálmándi, Rita, Nagy, Attila, Sarkady, Ferenc, Vasas, Nikolett, Sik, Máté, Lánczi, Levente István, Berényi, Ervin, Oláh, László, Crișan, Alexandra, Csiba, László, Bagoly, Zsuzsa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263307/ https://www.ncbi.nlm.nih.gov/pubmed/34234378 http://dx.doi.org/10.1371/journal.pone.0254253 |
Ejemplares similares
-
A modified in vitro clot lysis assay predicts outcomes and safety in acute ischemic stroke patients undergoing intravenous thrombolysis
por: Orbán-Kálmándi, Rita, et al.
Publicado: (2021) -
High Neutrophil–Lymphocyte Ratio and Low Lymphocyte–Monocyte Ratio Combination after Thrombolysis Is a Potential Predictor of Poor Functional Outcome of Acute Ischemic Stroke
por: Sadeghi, Farzaneh, et al.
Publicado: (2022) -
Incorporation of α2-Plasmin Inhibitor into Fibrin Clots and Its Association with the Clinical Outcome of Acute Ischemic Stroke Patients
por: Bagoly, Zsuzsa, et al.
Publicado: (2021) -
Stroke as a Potential Complication of COVID-19-Associated Coagulopathy: A Narrative and Systematic Review of the Literature
por: Szegedi, István, et al.
Publicado: (2020) -
PAI‐1 5G/5G genotype is an independent risk of intracranial hemorrhage in post‐lysis stroke patients
por: Szegedi, István, et al.
Publicado: (2019)